S.R. Mohan, M.J. Clemente, M. Afable, H.N. Cazzolli i inni. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia. „Haematologica”. 94 (10), s. 1407–1414, październik 2009. DOI: 10.3324/haematol.2009.009191. PMID: 19794084.
K.C. van Loenhout, S.C. Groves, M. Galazka, B. Sherman i inni. Early outcomes using alemtuzumab induction in lung transplantation. „Interact Cardiovasc Thorac Surg”. 10 (2), s. 190–194, luty 2010. DOI: 10.1510/icvts.2009.213892. PMID: 19939852.
S.R. Mohan, M.J. Clemente, M. Afable, H.N. Cazzolli i inni. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia. „Haematologica”. 94 (10), s. 1407–1414, październik 2009. DOI: 10.3324/haematol.2009.009191. PMID: 19794084.
K.C. van Loenhout, S.C. Groves, M. Galazka, B. Sherman i inni. Early outcomes using alemtuzumab induction in lung transplantation. „Interact Cardiovasc Thorac Surg”. 10 (2), s. 190–194, luty 2010. DOI: 10.1510/icvts.2009.213892. PMID: 19939852.
P.T. Pham, G.S. Lipshutz, P.T. Pham, J. Kawahji i inni. The evolving role of alemtuzumab (Campath-1H) in renal transplantation. „Drug Des Devel Ther”. 3, s. 41–49, 2009. PMID: 19920920.